期刊
DIABETES & VASCULAR DISEASE RESEARCH
卷 9, 期 2, 页码 89-94出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1479164112441477
关键词
Cardiovascular risk; clinical trials; PPAR / agonists; therapeutic strategies
资金
- Roche
The disappointing results of glucose lowering studies have highlighted the ongoing need to develop new therapeutic strategies to reduce cardiovascular risk in patients with type 2 diabetes. The presence of a range of metabolic abnormalities in diabetic patients presents a number of potential targets for therapeutic intervention. While modulation of peroxisome proliferator activated receptors (PPARs) represents an attractive approach, the results of studies of pharmacological agonists have been variable. The findings of these studies and rationale for development of dual PPAR-alpha/gamma agonists will be reviewed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据